Embedded Files
Sanguia supports care teams and workflows for translational cancer treatments and drug trials.
Appropriate Precision Oncology workflows reduce costs and make effective treatments available to more patients, sooner.
Did you know?
Most U.S. counties do not have new cancer drug trials available?
90% of safe FDA approved cancer drugs need more trials to become standard NCCN guideline treatments?
Sanguia is taking advantage of an improving FDA environment to make new lifesaving treatments available to:
Sanguia is taking advantage of an improving FDA environment to make new lifesaving treatments available to:
1: Collaborative care teams of specialist oncologists
2: Supporting geographically dispersed local primary care providers
3: For precision drug trials with pre-screened patients.
Modern Oncology Workflows are Genomic.
Modern Oncology Workflows are Genomic.
Idealized Precision Oncology workflows:
Idealized Precision Oncology workflows:
Start with Liquid Biopsy early detection.
Proceed with precision treatment matched to each individual's cancer's specific characteristics.
Succeed by sharing treatment trials reports and follow-up Minimal Residual Disease surveillance data.
Legacy medical methodology researches and treats cancer as a medical condition. With the onset of precision cancer antigen targeting, and other drug interventions the successful treatment of cancer is becoming more of a bio-engineering, data engineering and care coordination opportunity.
For Patients seeking help:
For Patients seeking help:
Sanguia recommends: CancerCommons.org
Translational Medicine
Translational Medicine
Improved genomic resources drive more effective treatments.
Improved genomic resources drive more effective treatments.
More efficient Lab- to-clinic processes save lives and reduce costs. Wider geographic reach increases the number of Patients treated and research data gathered.
Regulatory Frontiers
Regulatory Frontiers
An increased tolerance for ethical risk-taking will save more lives
An increased tolerance for ethical risk-taking will save more lives
The FDA is evolving to adapt to the special requirements of Precision Oncology with streamlined Genomic drug approval procedures.
Precision Oncology care team tools
Precision Oncology care team tools
Give your best care to more patients, now.
Give your best care to more patients, now.
Patients benefit from their Primary Care Provider's online orchestration of best-available precision Oncology treatments when specialist advisory teams and appropriate drugs are coordinated.
Features Include:
Easy HIPAA compliant online care team collaboration spaces.
Asynchronous Chat or real-time televideo care team consultation capabilities.
Enhanced ICD-10 genomic data and valuable FHIR datasharing.
Templates for geographically dispersed clinical trials databases
the Sanguia Flywheel:
the Sanguia Flywheel:
Expanding and accelerating effective treatment roll-out
Expanding and accelerating effective treatment roll-out
Life-saving care team and workflow tools
Earlier liquid biopsy detection
Faster genomic cancer characterization
Connecting geographically dispersed Patients and PCPs with appropriate researchers
Enabling effective precision translational treatment care.
Sharing treatment successes to promote more research
Surveillance follow-up of Minimal Residual Disease validating new treatments
Accelerating mainstreaming of faster validation and treatment.
We can reduce costs and increase reimbursements for precision oncology care.
We can reduce costs and increase reimbursements for precision oncology care.
Medicare will now reimburse next generation sequencing under some circumstances.
For Bitotech companies:
For Bitotech companies:
We consult on efficient precision oncology workflows and genomically -tuned pharma manufacturing. Robotic gripper adaptations, QR tracking and logging, and wet lab and CLIA management system integrations. Scaled up sequencing. Nuclear medicine pharmacy and production expertise.
For Precision Oncology service companies:
For Precision Oncology service companies:
Improve biopsy and treatment logistics.
We Recruit cost efficient contract biotech and robotics workers for biotech companies.
We Recruit cost efficient contract biotech and robotics workers for biotech companies.
Headlines:
Headlines:
FDA Commisioner Dr.Marty Makary calls for citizen scientist innovation
FDA Commisioner Dr.Marty Makary calls for citizen scientist innovation
The FDA must work to speed up the drug approval process, challenging the notion that new treatments must take over a decade to reach the market.
phylo.bio launches with $13.5 million seed round from Andreeson.
Does Private Equity profit pressure Improve care?
Does Private Equity profit pressure Improve care?
Drawn by high demand and Medicare reimbursement rules that reward expensive drugs and procedures, private equity firms have acquired hundreds of oncology practices nationwide.
Weill family commits $100 million for West Coast cancer hub
Weill family commits $100 million for West Coast cancer hub
On Sanguia's home turf, the University of California, San Francisco (UCSF) and Stanford Medicine have announced a $100 million matching grant from the Weill Family Foundation to bring together two leading cancer centers to launch the Weill Cancer Hub West.
On Sanguia's home turf, the University of California, San Francisco (UCSF) and Stanford Medicine have announced a $100 million matching grant from the Weill Family Foundation to bring together two leading cancer centers to launch the Weill Cancer Hub West.
Google Sites
Report abuse